Melatonin ameliorates intrarenal renin–angiotensin system in a 5/6 nephrectomy rat model
- 266 Downloads
Activation of the intrarenal renin–angiotensin system (RAS) plays a critical role in the pathophysiology of chronic kidney disease (CKD) and hypertension. It has been reported that reactive oxygen species (ROS) are important components of intrarenal RAS activation. Melatonin is recognized as a powerful antioxidant, and we recently reported that impaired nighttime melatonin secretion correlates negatively with urinary angiotensinogen excretion, the surrogate marker of intrarenal RAS activity in patients with CKD. However, whether melatonin supplementation ameliorates the augmentation of intrarenal RAS in CKD has remained unknown. We aimed to clarify whether exogenous melatonin ameliorates intrarenal RAS activation via the reduction of ROS production.
5/6 Nephrectomized (Nx) rats were used as a chronic progressive CKD model and compared with sham-operated control rats. The Nx rats were divided into untreated Nx rats and melatonin-treated Nx rats. The levels of intrarenal RAS, ROS components, and renal injury were evaluated after 4 weeks of treatment.
Compared with the control rats, the untreated Nx rats exhibited significant increases in intrarenal angiotensinogen, angiotensin II (AngII) type 1 receptors, and AngII, accompanied by elevated blood pressure, higher oxidative stress (8-hydroxy-2′-deoxyguanosine), lower antioxidant (superoxide dismutase) activity, and increased markers of interstitial fibrosis (α-smooth muscle actin, Snail, and type I collagen) in the remnant kidneys. Treatment with melatonin significantly reversed these abnormalities.
Antioxidant treatment with melatonin was shown to ameliorate intrarenal RAS activation and renal injury in a 5/6 Nx rat model.
KeywordsMelatonin Intrarenal renin–angiotensin system Oxidative stress 5/6 Nephrectomy Blood pressure Chronic kidney disease
This study was supported by grants from Young Investigator Research Projects of Hamamatsu University School of Medicine in 2015 (Awarded to Sayaka Ishigaki).
Compliance with ethical standards
Conflict of interest
The authors have no conflicts of interest to declare.
All procedures performed in studies involving animals were in accordance with the ethical standards of the Animal Committee of the Hamamatsu University School of Medicine (No. 2015088).
- 8.Xue H, Yuan P, Ni J, Li C, Shao D, Liu J, Shen Y, Wang Z, Zhou L, Zhang W, Huang Y, Yu C, Wang R, Lu L. H2S inhibits hyperglycemia-induced intrarenal renin–angiotensin system activation via attenuation of reactive oxygen species generation. PLoS One. 2013;8:e74366.CrossRefPubMedPubMedCentralGoogle Scholar
- 14.Ishigaki S, Ohashi N, Isobe S, Tsuji N, Iwakura T, Ono M, Sakao Y, Tsuji T, Kato A, Miyajima H, Yasuda H. Impaired endogenous nighttime melatonin secretion relates to intrarenal renin–angiotensin system activation and renal damage in patients with chronic kidney disease. Clin Exp Nephrol. 2016;20:878–84.CrossRefPubMedGoogle Scholar
- 20.Huang Y, Yamamoto T, Misaki T, Suzuki H, Togawa A, Ohashi N, Fukasawa H, Fujigaki Y, Ichihara A, Nishiyama A, Senbonmatsu T, Ikegaya N, Hishida A. Enhanced intrarenal receptor-mediated prorenin activation in chronic progression anti-thymocyte serum nephritis rats on high salt intake. Am J Physiol Renal Physiol. 2012;303:F130–8.CrossRefPubMedGoogle Scholar
- 22.Ohashi N, Yamamoto T, Huang Y, Misaki T, Fukasawa H, Suzuki H, Togawa A, Suzuki S, Fujigaki Y, Nakagawa T, Nakamura Y, Suzuki F, Kitagawa M, Hishida A. Intrarenal RAS activity and urinary angiotensinogen excretion in anti-thymocyte serum nephritis rats. Am J Physiol Renal Physiol. 2008;295:F1512–8.CrossRefPubMedGoogle Scholar
- 25.Nishiyama A, Konishi Y, Ohashi N, Morikawa T, Urushihara M, Maeda I, Hamada M, Kishida M, Hitomi H, Shirahashi N, Kobori H, Imanishi M. Urinary angiotensinogen reflects the activity of intrarenal renin–angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant. 2011;26:170–7.CrossRefPubMedGoogle Scholar
- 35.Abdo S, Shi Y, Otoukesh A, Ghosh A, Lo CS, Chenier I, Filep JG, Ingelfinger JR, Zhang SL, Chan JS. Catalase overexpression prevents nuclear factor erythroid 2-related factor 2 stimulation of renal angiotensinogen gene expression, hypertension, and kidney injury in diabetic mice. Diabetes. 2014;63:3483–96.CrossRefPubMedPubMedCentralGoogle Scholar